[Benzodiazepines, receptor affinity, their endogenous ligands and the modeling of new psychotropic preparations].
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001569:Benzodiazepines; D002243:Carbolines / Q000494:pharmacology; D002352:Carrier Proteins / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D050485:GABA Plasma Membrane Transport Proteins; D007288:Inosine / Q000494:pharmacology; D008024:Ligands; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; D051379:Mice; D008956:Models, Chemical; D009419:Nerve Tissue Proteins / Q000494:pharmacology; D009536:Niacinamide / Q000031:analogs & derivatives / Q000494:pharmacology; D027361:Organic Anion Transporters; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects*; D012995:Solubility; D013329:Structure-Activity Relationship
D014151:Anti-Anxiety Agents; D002243:Carbolines; D002352:Carrier Proteins; D050485:GABA Plasma Membrane Transport Proteins; D008024:Ligands; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D027361:Organic Anion Transporters; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D009536:Niacinamide; D007288:Inosine
Benzodiazepiny, affinnost' k retseptoram, ikh éndogennye ligandy, modelirovanie novykh psikhotropnykh preparatov.